1. Anupama Kotha 1, Simar J. Singh 1, William B. Trattler 1,2, Carlos Buznego 1,2 The authors have no financial interest in the subject matter of this poster Dr. Buznego has received funding for research, consulting and/or speaking from: Alcon; Bausch+Lomb Dr. Trattler has received funding for research, consulting and/or speaking from: Advanced Medical Optics 1 Herbert Wertheim College of Medicine, Florida International University, Miami, FL 2 Center for Excellence in Eye Care, Miami FL

2. Purpose To evaluate the efficacy of cataract surgery with presbyopic intraocular lens (IOL) insertion in mild/moderate glaucomatous versus non-glaucomatous eyes.

3. Methods Retrospective, single center, multi-surgeon study including 55 eyes of 39 cataract surgery patients with or without mild/moderate glaucoma receiving a presbyopic IOL (Restor D1 & D3, Crystalens HD & AT50SE, or Tecnis Multifocal) between 2005 and 2010. 21 glaucoma patients (24 eyes; mean age 76.4y; 42.9% male) Pre-Op VF Data: Avg. MD = -3.5; Range = -1.17 to -7.58 Lenses: Restor (n=20), Crystalens (n=3), Tecnis (n=1) 18 non-glaucomatous control patients (31 eyes, mean age 67.6y, 44.4% males) Lenses: Restor (n=21), Crystalens (n=4), Tecnis (n=6) UCVA, BCVA, and near acuity were measured one month following IOL insertion. Post-operative enhancement procedures were recorded. No patients required IOL removal. One glaucomatous patient required excimer laser treatment for residual refractive error.

4. Results % of eyes achieving a post-op UCVA of 20/25 or better was comparable: 47.8% of glaucomatous and 45.2% of control eyes. % of eyes achieving a post-op UCVA of 20/40 or better was also similar: 91.3% of glaucomatous and 83.9% of control eyes % of eyes achieving a post-op BCVA of 20/25 or better was comparable: 65.0% of glaucomatous eyes and 75.0% of control eyes % of eyes achieving a post-op BCVA of 20/40 or better was equal: 100% of glaucomatous eyes and 100% of control eyes % of eyes achieving an uncorrected near visual acuity of J3 or better was not significantly different: 79.2% of glaucomatous eyes and 92.6% of control eyes

5. Results: Visual Acuity 1 month Post-Op Group# of eyesUCVA ≤ 20/25 UCVA ≤ 20/40 BCVA ≤ 20/25 BCVA ≤ 20/40 Glaucoma2447.8%91.3%65%100% Control3145.2%83.9%75%100%

6. Conclusions Patients with mild/moderate glaucoma receiving presbyopic IOLs obtained distance and near visual outcomes comparable to non-glaucomatous patients receiving similar presbyopic IOLs. Our results indicate that glaucoma patients may benefit from presbyopic IOL insertion.